These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 6138087)

  • 1. Midazolam and sleep in insomniac patients.
    Monti JM; Debellis J; Alterwain P; D'Angelo L
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):87S-88S. PubMed ID: 6138087
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sleep laboratory study of the effects of midazolam in insomniac patients.
    Monti JM; Debellis J; Gratadoux E; Alterwain P; Altier H; D'Angelo L
    Eur J Clin Pharmacol; 1982; 21(6):479-84. PubMed ID: 7075654
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of midazolam on sleep of insomniacs.
    Vogel GW; Vogel F
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):103S-108S. PubMed ID: 6138060
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Automatic scoring of polygraphic sleep recordings: midazolam in insomniacs.
    Gath I; Bar-On E; Rogowski Z; Bental E
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):89S-96S. PubMed ID: 6138088
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Objective assessment of sleep patterns resulting from benzodiazepines prescribed by general practitioners.
    Wauquier A; Declerck A
    Neuropsychobiology; 1990-1991; 24(2):57-60. PubMed ID: 1983700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sleep laboratory and performance evaluation of midazolam in insomniacs.
    Hauri P; Roth T; Sateia M; Zorick F
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):109S-114S. PubMed ID: 6138061
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insomnia in generalized anxiety disorder: polysomnographic, psychometric and clinical investigations before, during and after therapy with a long- versus a short-half-life benzodiazepine (quazepam versus triazolam).
    Saletu B; Anderer P; Brandstätter N; Frey R; Grünberger J; Klösch G; Mandl M; Wetter T; Zeitlhofer J
    Neuropsychobiology; 1994; 29(2):69-90. PubMed ID: 8170529
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of midazolam and temazepam on sleep and performance when administered in the middle of the night.
    Roth T; Hauri P; Zorick F; Sateia M; Roehrs T; Kipp J
    J Clin Psychopharmacol; 1985 Apr; 5(2):66-9. PubMed ID: 2859305
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Midazolam: dose-response studies of effectiveness and rebound insomnia.
    Kales A; Soldatos CR; Bixler EO; Goff PJ; Vela-Bueno A
    Pharmacology; 1983; 26(3):138-49. PubMed ID: 6132414
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of midazolam on transient insomnia.
    Monti JM; Boussard M; Olivera S; Labraga P; Alvariño F
    Eur J Clin Pharmacol; 1993; 44(6):525-7. PubMed ID: 8405006
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative clinical studies with midazolam, oxazepam and placebo.
    Feldmeier C; Kapp W
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):151S-155S. PubMed ID: 6138069
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Short-term sleep laboratory evaluation of midazolam in chronic insomniacs. Preliminary results.
    Monti JM; Alterwain P; Debellis J; Altier H; Pellejero T; Monti D
    Arzneimittelforschung; 1987 Jan; 37(1):54-7. PubMed ID: 3551970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the efficacy and tolerance of orally administered midazolam as hypnotic agent compared with oxazepam in the treatment of insomnia of mild to moderate severity.
    Helcl I; Lupolover R; Buch JP; Amrein R
    Arzneimittelforschung; 1981; 31(12a):2284-7. PubMed ID: 6120705
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypnotic efficacy of temazepam: a long-term sleep laboratory evaluation.
    Mitler MM; Carskadon MA; Phillips RL; Sterling WR; Zarcone VP; Spiegel R; Guilleminault C; Dement WC
    Br J Clin Pharmacol; 1979; 8(1):63S-68S. PubMed ID: 41543
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of efficacy and safety of midazolam administered orally in sleep disorders. A dose-finding study.
    Lupolover R; Buch JP
    Arzneimittelforschung; 1981; 31(12a):2281-3. PubMed ID: 6120704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative study of midazolam and vesparax in moderate or severe insomnia in female surgical patients.
    Philipp E; Kapp W
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):161S-165S. PubMed ID: 6138071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trimipramine in primary insomnia: results of a polysomnographic double-blind controlled study.
    Riemann D; Voderholzer U; Cohrs S; Rodenbeck A; Hajak G; Rüther E; Wiegand MH; Laakmann G; Baghai T; Fischer W; Hoffmann M; Hohagen F; Mayer G; Berger M
    Pharmacopsychiatry; 2002 Sep; 35(5):165-74. PubMed ID: 12237787
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy without tolerance or rebound insomnia for midazolam and temazepam after use for one to three months.
    Allen RP; Mendels J; Nevins DB; Chernik DA; Hoddes E
    J Clin Pharmacol; 1987 Oct; 27(10):768-75. PubMed ID: 2892863
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Midazolam and oxazepam in the treatment of insomnia in hospitalized patients.
    Gallais H; Casanova P; Fabregat H
    Br J Clin Pharmacol; 1983; 16 Suppl 1(Suppl 1):145S-149S. PubMed ID: 6138068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EEG sleep studies of insomniacs under flunitrazepam treatment.
    Gaillard JM; Tissot R
    Int Pharmacopsychiatry; 1975; 10(4):199-207. PubMed ID: 2563
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.